Cell Source, Inc. (CLCS)
0.93
+0.13
(+16.25%)
USD |
OTCM |
Apr 16, 16:00
Cell Source Research and Development Expense (Annual) : 1.898M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Celldex Therapeutics, Inc. | 241.69M |
| Plus Therapeutics, Inc. | 8.379M |
| Atossa Therapeutics, Inc. | 21.18M |
| Abeona Therapeutics, Inc. | 24.26M |
| Kiora Pharmaceuticals, Inc. | 3.714M |